文献速递妇科

英国国家卫生与临床优化研究所「超根治性(广泛)手术治疗晚期卵巢癌」指南分类不能有效预测术后并发症:一项队列研究

The NICE classification for 'Ultra-radical (extensive) surgery for advanced ovarian cancer' guidance does not meaningfully predict postoperative complications: a cohort study.
PubMed 文献 · BJOG · 2018-09-09

本研究回顾性分析2007年8月16日至2017年2月16日114个月间英国一家妇科癌症中心608例晚期卵巢癌手术患者的病历,比较六种手术范围分类方式对术后严重并发症(3-5级)的预测能力。结果显示多次肠切除的RR为7.73(95%CI 3.92-15.26),高手术复杂评分(SCS)的RR为6.12(95%CI 3.25-11.52),均优于NICE「超根治性手术」分类(RR 4.65,95%CI 2.26-8.79)。作者建议使用SCS定义高风险手术,并呼吁NICE重新评估「超根治性」手术这一术语。

要点

  • 多次肠切除对3-5级并发症的预测最强(RR 7.73,95%CI 3.92-15.26)。
  • 高SCS的RR为6.12(95%CI 3.25-11.52),优于NICE超根治性分类。
  • NICE超根治性手术的RR为4.65(95%CI 2.26-8.79)。

核心结论

  • 手术操作数量与严重并发症显著相关,且比是否实施某些「高风险」操作更能预测术后严重并发症。
  • 作者建议使用SCS定义高风险手术,并认为NICE应重新评估「超根治性」手术这一术语的使用。

研究设计与样本

  • 回顾性病历审查,纳入英国一家妇科癌症中心2007年8月16日至2017年2月16日114个月间因晚期卵巢癌手术的608例女性。
  • 采用六种手术范围分类方法分析结局:标准/超根治性手术;标准/根治性/超根治性手术;有无胃肠道切除;低/中/高手术复杂评分(SCS);有无肠吻合和/或膈肌手术;有无多次肠切除。
  • 主要结局指标为严重(3-5级)术后并发症和死亡。

主要发现

  • 43例(7.1%)患者发生严重并发症,6例(1.0%)发生5级并发症。
  • 与NICE定义的标准手术相比,多次肠切除患者3-5级并发症的RR为7.73(95%CI 3.92-15.26),高SCS患者RR为6.12(95%CI 3.25-11.52),膈肌手术加胃肠道吻合患者RR为5.57(95%CI 2.65-11.72),任何胃肠道切除患者RR为4.69(95%CI 2.66-8.24),超根治性手术患者RR为4.65(95%CI 2.26-8.79),超根治性手术患者RR为4.20(95%CI 2.35-7.51)。
  • 在中间复杂手术队列中,标准手术(6/59,10.2%)与超根治性手术(9/81,11.1%)的严重并发症发生率无显著差异(P > 0.05)。

临床怎么用

  • 作者建议使用SCS定义高风险手术。
  • 作者认为NICE应重新评估「超根治性」手术这一术语的使用。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine which descriptors of cytoreductive surgical extent in advanced ovarian cancer (AOC) best predict postoperative morbidity. DESIGN: Retrospective notes review. SETTING: A gynaecological cancer centre in the UK. POPULATION: Six hundred and eight women operated on for AOC over a period of 114 months at a tertiary cancer centre, between 16 August 2007 and 16 February 2017. METHODS: Outcome data were analysed by six approaches to classify the extent of surgery: standard/ultra-radical surgery; standard/radical/supra-radical surgery; presence/absence of gastrointestinal resections; low/intermediate/high surgical complexity score (SCS); presence of bowel anastomoses and/or diaphragmatic surgery; and the presence/absence of multiple bowel resections. MAIN OUTCOME MEASURES: Major (grades 3-5) postoperative morbidity and mortality. RESULTS: Forty-three (7.1%) patients experienced major complications. Grade-5 complications occurred in six patients (1.0%). Patients who underwent multiple bowel resections had a relative risk (RR) of 7.73 (95% confidence interval, 95% CI 3.92-15.26), patients with a high SCS had an RR of 6.12 (95% CI 3.25-11.52), patients with diaphragmatic surgery and gastrointestinal anastomosis had an RR of 5.57 (95% CI 2.65-11.72), patients with 'any gastrointestinal resection' had an RR of 4.69 (95% CI 2.66-8.24), patients with ultra-radical surgery had an RR of 4.65 (95% CI 2.26-8.79), and patients with supra-radical surgery had an RR of 4.20 (95% CI 2.35-7.51) of grades 3-5 morbidity, compared with patients undergoing standard surgery as defined by the National Institute for Health and Care Excellence (NICE) in the UK. No significant difference was seen in the rate of major morbidity between standard (6/59, 10.2%) and ultra-radical (9/81, 11.1%) surgery within the cohort who had intermediate complex surgery (P > 0.05). CONCLUSIONS: The numbers of procedures performed significantly correlate with major morbidity. The number of procedures performed better predicted major postoperative morbidity than the performance of certain 'high risk' procedures. We recommend using SCS to define a higher risk operation. NICE should re-evaluate the use of the term 'ultra-radical' surgery. TWEETABLE ABSTRACT: Multiple bowel resection is the best predictor of morbidity and is more predictive than 'ultra-radical surgery'.

来源:BJOG,查看原文。版权归原作者所有。

引用

  1. Phillips A, Sundar S, Singh K, et al. The NICE classification for 'Ultra-radical (extensive) surgery for advanced ovarian cancer' guidance does not meaningfully predict postoperative complications: a cohort study. BJOG. 2018. PMID: 30092615. doi:10.1111/1471-0528.15423

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。